NCT04730024View on ClinicalTrials.gov

Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj

Not yet recruitingOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

March 27, 2022

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions
Atopic Dermatitis
Interventions
OTHER

Not applicable(observational study)

Not applicable(observational study)

Trial Locations (1)

Unknown

Dongguk University Medical Center, Ilsan

All Listed Sponsors
lead

Kang Stem Biotech Co., Ltd.

INDUSTRY

NCT04730024 - Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj | Biotech Hunter | Biotech Hunter